全球益生菌原料市场：策略性洞察与预测（2026-2031年）

全球益生菌市场预计将从 2026 年的 33 亿美元成长到 2031 年的 47 亿美元，复合年增长率为 7.3%。

世界のプロバイオティクス原料市场は、より広范な机能性栄养およびニュートラシューティカル（机能性食品）のエコシステムにおける重要な构成要素となっています。プロバイオティクス原料は、适切な量を摂取することで健康上の利益をもたらす生きた微生物から成ります。これらの原料は、机能性食品、栄养补助食品、饮料、および动物用饲料の配合に広く取り入れられています。肠内环境の健康や予防医疗に対する消费者の意识の高まりが、世界市场全体でプロバイオティクスを配合した製品への需要を牵引しています。食品、饮料、およびニュートラシューティカル製品のメーカーは、自社製品の栄养価と机能性を高めるため、プロバイオティクス菌株をますます多く配合しています。また、科学的に実证された健康効果の主张や菌株固有の有効性を重视する规制动向も、市场に影响を与えています。その结果、原料サプライヤーは、実证済みの机能的効果を持つ高品质なプロバイオティクス菌株を提供するために、临床研究开発や高度な生产能力への投资を进めています。こうした构造的な动向により、プロバイオティクス原料は、现代の健康志向の饮食品やサプリメントの配合において不可欠な成分としての地位を确立しつつあります。

市场驱动因素

プロバイオティクス原料市场の主要な市场促进要因の一つは、予防医疗と消化器の健康に対する世界の関心の高まりです。消费者は、全身の健康、免疫力、代谢机能における肠内细菌丛の役割について、より意识するようになっています。このような消费者の行动の変化は、プロバイオティクスを豊富に含む食品、饮料、および栄养补助食品の消费を促进しています。机能性食品メーカーは、健康増进製品に対する高まる消费者需要に応えるため、プロバイオティクス菌株を配合した製品ラインナップを拡大しています。

もう一つの重要な成长要素は、动物栄养分野におけるプロバイオティクスの利用拡大です。多くの地域で、抗菌薬耐性への悬念から、政府や业界団体が畜产における抗生物质成长促进剤の使用を段阶的に廃止しています。プロバイオティクス原料は、动物の肠内环境と成长パフォーマンスを改善する効果的な代替手段となります。したがって、抗生物质を使用しない畜产への移行により、饲料业界におけるプロバイオティクス原料の需要が加速しています。

发酵食品和饮料日益普及，也推动了市场扩张。消费者越来越倾向于选择天然来源的益生菌，并将其融入日常食品中，例如优格、发酵饮料和其他功能性乳製品。这种消费趋势带动了对能够耐受生产和储存条件的高稳定性益生菌菌株的需求。

市场限制因素

儘管益生菌原料市场成长前景强劲，但仍面临许多监管和技术方面的挑战。其中一个主要限制因素是对益生菌产品健康声明的严格监管。某些地区的监管机构限制在产品标籤上使用「益生菌」一词，并要求提供大量的临床证据来支持其功能性声明。这些要求可能会增加原料生产商的研发成本。

在整个生产和分销过程中保持微生物稳定性也是一项技术挑战。益生菌必须在加工、包装、储存以及通过消化道的过程中存活下来，才能发挥其健康益处。确保稳定性需要先进的包埋技术和可控的生产环境，这会增加生产的复杂性和成本。

对技术和细分市场的洞察

全球益生菌原料市场按类型、形态、应用和地区细分。按类型划分，市场包括细菌和酵母来源的益生菌原料。由于在食品和膳食补充剂应用领域获得了广泛的科学检验和监管核准，细菌菌株，特别是乳桿菌属和双叉桿菌属的菌株，占据了市场主导地位。

从形态上看，益生菌原料分为干粉和液体两种。干粉益生菌培养物因其稳定性更高，更适合大规模生产工艺，而被广泛应用。

按应用领域划分，益生菌市场包括食品饮料、营养补充品和动物饲料。其中，食品饮料领域的需求量最大，主要受功能性乳製品和益生菌饮料消费量成长的推动。营养补充品也是一个重要的市场，因为消费者需要胶囊、粉剂和软糖等便利的益生菌製剂。

地域别に见ると、市场は北米、欧州、アジア太平洋、南米、中东・アフリカに広がっています。アジア太平洋地域では、発酵食品の消费が広く普及していることや、新兴経済国における机能性食品产业の拡大により、需要が特に旺盛です。

竞争格局与策略展望

益生菌原料市场的竞争格局主要由少数几家拥有强大研发能力的全球生技公司和原料生产商主导。市场主导主要取决于独特的微生物菌株库、发酵能力和临床研究成果。主要企业透过提供经临床检验的益生菌菌株和产品配方技术支援来脱颖而出。

许多原料供应商正将业务拓展至简单菌种生产以外的领域，涵盖配方研发、法规支援以及包含客製化益生菌混合物在内的综合解决方案。对菌株开发、发酵技术和先进包埋技术的策略性投资正在增强其在产业中的竞争力。

重点

随着消费者对功能性营养食品和预防性医药产品的需求持续成长，全球益生菌市场预计将稳定扩张。人们对肠道健康的日益关注、益生菌补充剂的日益普及以及畜牧业向无抗生素养殖模式的转变，都在推动市场成长。儘管监管方面的复杂性和微生物稳定性方面的挑战仍然是重要的考虑因素，但技术进步和益生菌菌株的科学检验有望支撑市场的长期发展。

本报告的主要益处

• 深入分析：获得跨地区、客户群、政策、社会经济因素、消费者偏好和产业领域的详细市场洞察。
• 竞争格局：我们了解主要企业的策略倡议，并确定最佳的市场进入方式。
• 市场驱动因素与未来趋势：我们评估影响市场的关键成长要素和新兴趋势。
• 实用建议：我们支援制定策略决策以开发新的收入来源。
• 适合各类读者：非常适合Start-Ups、研究机构、顾问公司、中小企业和大型企业。

我们的报告的使用范例

产业和市场洞察、机会评估、产品需求预测、打入市场策略、区域扩张、资本投资决策、监管分析、新产品开发和竞争情报。

报告范围

• 2021年至2025年的历史数据和2026年至2031年的预测数据
• 成长机会、挑战、供应链前景、法律规范与趋势分析
• 竞争定位、策略和市场占有率评估
• 细分市场和区域销售成长及预测评估
• 公司简介，包括策略、产品、财务状况和主要发展动态。

目录

第一章执行摘要

第二章：市场概述

• 市场概览
• 市场的定义
• 调查范围
• 市场区隔

第三章：商业环境

• 市场驱动因素
• 市场限制因素
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

第五章：全球益生菌市场：按类型划分

• 细菌
  • 乳酸桿菌
  • 双歧桿菌
• 酵母菌

第六章：全球益生菌原料市场：以剂型划分

• 干粉
• 液体

第七章 全球益生菌市场：依应用划分

• 发酵食品和饮料
• 营养补充品
• 动物饲料
• 其他的

第八章 全球益生菌原料市场：依地区划分

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 台湾
  • 其他的

第九章：竞争环境与分析

• 主要企业及策略分析
• 市占率分析
• 合併、收购、协议和合作关係
• 竞争环境仪錶板

第十章：公司简介

• Kerry Group, Plc
• Novonesis Group
• DSM-Firmenich
• Lallemand Inc
• Associated British Foods PLC
• Nutris Ingredients
• Archer Daniels Midland Company
• Nestle SA
• Danone SA
• Advanced Enzyme Technologies
• BioGaia AB

第十一章附录

The Global Probiotics Ingredients Market will grow from USD 3.3 billion in 2026 to USD 4.7 billion in 2031, at a 7.3% CAGR.

The global probiotics ingredients market forms a key component of the broader functional nutrition and nutraceutical ecosystem. Probiotic ingredients consist of live microorganisms that provide health benefits when consumed in adequate quantities. These ingredients are widely incorporated into functional foods, dietary supplements, beverages, and animal feed formulations. Growing consumer awareness regarding gut health and preventive healthcare is driving demand for probiotic-enriched products across global markets. Manufacturers of food, beverage, and nutraceutical products increasingly incorporate probiotic strains to enhance the nutritional value and functional appeal of their offerings. The market is also influenced by regulatory developments that emphasize scientifically validated health claims and strain-specific efficacy. As a result, ingredient suppliers are investing in clinical research and advanced production capabilities to deliver high-quality probiotic strains with proven functional benefits. These structural dynamics are positioning probiotic ingredients as essential components within modern health-focused food and supplement formulations.

Market Drivers

One of the primary drivers of the probiotics ingredients market is the increasing global focus on preventive healthcare and digestive wellness. Consumers are becoming more conscious of the role of gut microbiota in overall health, immunity, and metabolic function. This shift in consumer behavior is encouraging the consumption of probiotic-enriched foods, beverages, and dietary supplements. Functional food manufacturers are expanding product portfolios that incorporate probiotic cultures to meet rising consumer demand for health-enhancing products.

Another key growth driver is the increasing use of probiotics in animal nutrition. Governments and industry associations in many regions are phasing out antibiotic growth promoters in livestock production due to concerns about antimicrobial resistance. Probiotic ingredients serve as effective alternatives that improve gut health and growth performance in animals. The transition toward antibiotic-free livestock production is therefore accelerating demand for probiotic ingredients in the animal feed industry.

The growing popularity of fermented foods and beverages also contributes to market expansion. Consumers increasingly prefer natural sources of probiotics delivered through everyday foods such as yogurt, fermented drinks, and other functional dairy products. These consumption patterns strengthen the demand for stable probiotic cultures that can survive manufacturing and storage conditions.

Market Restraints

Despite favorable growth prospects, the probiotics ingredients market faces several regulatory and technical challenges. One major constraint is the strict regulatory environment governing health claims associated with probiotic products. Regulatory authorities in certain regions impose restrictions on the use of the term "probiotic" in product labeling or require extensive clinical evidence to support functional claims. These requirements can increase development costs for ingredient manufacturers.

Maintaining microbial stability throughout the manufacturing and distribution process also presents technical challenges. Probiotic microorganisms must remain viable during processing, packaging, storage, and gastrointestinal transit in order to deliver health benefits. Ensuring stability requires advanced encapsulation technologies and controlled production environments, which can increase manufacturing complexity and costs.

Technology and Segment Insights

The global probiotics ingredients market is segmented by type, form, application, and geography. By type, the market includes bacteria-based and yeast-based probiotic ingredients. Bacteria strains dominate the market, particularly Lactobacillus and Bifidobacterium species, due to their extensive scientific validation and regulatory acceptance in food and supplement applications.

Based on form, probiotic ingredients are available in dry and liquid formats. Dry probiotic cultures are widely used due to their improved stability and compatibility with large-scale manufacturing processes.

In terms of application, the market includes food and beverages, dietary supplements, and animal feed. The food and beverage segment represents the largest share of demand, driven by increasing consumption of functional dairy products and probiotic beverages. Dietary supplements also represent a significant segment as consumers seek convenient probiotic formulations such as capsules, powders, and gummies.

Geographically, the market spans North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Demand is particularly strong in Asia Pacific due to widespread consumption of fermented foods and expanding functional food industries across emerging economies.

Competitive and Strategic Outlook

The competitive landscape of the probiotics ingredients market is characterized by a limited number of global bioscience and ingredient companies with extensive research capabilities. Market leadership is largely determined by proprietary microbial strain collections, fermentation capacity, and clinical research portfolios. Leading companies differentiate themselves by offering clinically validated probiotic strains and technical support for product formulation.

Many ingredient suppliers are moving beyond basic culture production toward integrated solutions that include formulation expertise, regulatory support, and customized probiotic blends. Strategic investments in strain development, fermentation technology, and advanced encapsulation techniques are strengthening competitive positioning within the industry.

Key Takeaways

The global probiotics ingredients market is expected to expand steadily as consumer demand for functional nutrition and preventive healthcare products continues to rise. Growing awareness of gut health, increasing adoption of probiotic supplements, and the transition toward antibiotic-free animal farming are supporting market growth. While regulatory complexities and microbial stability challenges remain important considerations, technological advancements and scientific validation of probiotic strains are expected to sustain long-term development of the market.

Key Benefits of this Report

• Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What businesses use our reports for

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2025 and forecast data from 2026 to 2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PROBIOTICS INGREDIENTS MARKET BY TYPE

• 5.1. Introduction
• 5.2. Bacteria
  • 5.2.1. Lactobacillus
  • 5.2.2. Bifidobacterium
• 5.3. Yeast

6. PROBIOTICS INGREDIENTS MARKET BY FORM

• 6.1. Introduction
• 6.2. Dry/Powder
• 6.3. Liquid

7. PROBIOTICS INGREDIENTS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Fermented Foods & Drinks
• 7.3. Dietary Supplement
• 7.4. Animal Feed
• 7.5. Others

8. PROBIOTICS INGREDIENTS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Taiwan
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Kerry Group, Plc
• 10.2. Novonesis Group
• 10.3. DSM-Firmenich
• 10.4. Lallemand Inc
• 10.5. Associated British Foods PLC
• 10.6. Nutris Ingredients
• 10.7. Archer Daniels Midland Company
• 10.8. Nestle S.A
• 10.9. Danone S.A
• 10.10. Advanced Enzyme Technologies
• 10.11. BioGaia AB

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations